Title 42 — The Public Health and Welfare
Part C · Chapter 6A — Public Health Service
§ 285s. Purpose of Institute
Statutory text
General purpose
The general purpose of the National Human Genome Research Institute (in this subpart referred to as the “Institute”) is to characterize the structure and function of the human genome, including the mapping and sequencing of individual genes. Such purpose includes—
planning and coordinating the research goal of the genome project;
reviewing and funding research proposals;
developing training programs;
coordinating international genome research;
communicating advances in genome science to the public; and
reviewing and funding proposals to address the ethical and legal issues associated with the genome project (including legal issues regarding patents).
Research training
The Director of the Institute may conduct and support research training—
for which fellowship support is not provided under section 288 of this title; and
that is not residency training of physicians or other health professionals.
Amount available for ethical and legal issues
Except as provided in paragraph (2), of the amounts appropriated to carry out subsection (a) for a fiscal year, the Director of the Institute shall make available not less than 5 percent for carrying out paragraph (6) of such subsection.
With respect to providing funds under subsection (a)(6) for proposals to address the ethical issues associated with the genome project, paragraph (1) shall not apply for a fiscal year if the Director of the Institute certifies to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, that the Director has determined that an insufficient number of such proposals meet the applicable requirements of sections 289 and 289a of this title.
Legislative history
Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.
National Institutes of Health Revitalization Act of 1993
Pub. L. 103–43 title XV § 1521(2) · 107 Stat. 122
Enacted · 42 U.S.C. § 285s
July 1, 1944, ch. 373, title IV, § 464z–1, formerly § 485B, as added Pub. L. 103–43, title XV, § 1521(2), June 10, 1993, 107 Stat. 180
Source evidence
Code source credit
July 1, 1944, ch. 373, title IV, § 464z–1, formerly § 485B, as added Pub. L. 103–43, title XV, § 1521(2), June 10, 1993, 107 Stat. 180Enacted provision · exact public law section
(2) in part E, by adding at the end the following subpart: “Subpart 3— National Center for Human Genome Research “purpose of the center “Sec. 485B. (a) The general purpose of the National Center for Human Genome Research (in this subpart referred to as the ‘Center’) is to characterize the structure and function of the human genome, including the mapping and sequencing of individual genes. Such purpose includes— “(1) planning and coordinating the research goal of the genome project; “(2) reviewing and funding research proposals; “(3) developing training programs; “(4) coordinating international genome research; “(5) communicating advances in genome science to the public; and “(6) reviewing and funding proposals to address the ethical and legal issues associated with the genome project (including legal issues regarding patents). “(b) The Director of the Center may conduct and support research training— “(1) for which fellowship support is not provided under section 487; and “(2) that is not residency training of physicians or other health professionals. “(c) (1) Except as provided in paragraph (2), of the amounts appropriated to carry out subsection (a) for a fiscal year, the Director of the Center shall make available not less than 5 percent for carrying out paragraph (6) of such subsection. “(2) With respect to providing funds under subsection (a)(6) for proposals to address the ethical issues associated with the genome project, paragraph (1) shall not apply for a fiscal year if the Director of the Center certifies to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, that the Director has determined that an insufficient number of such proposals meet the applicable requirements of sections 491 and 492.”.National Institutes of Health Reform Act of 2006
Pub. L. 109–482 § 101(c)(4)(C) · 120 Stat. 3675
Substituted · 42 U.S.C. § 285s
Pub. L. 109–482, § 101(c)(4)(C), substituted “Institute” for “Center” wherever appearing in section catchline and text
Source evidence
Code amendment note
Pub. L. 109–482, § 101(c)(4)(C), substituted “Institute” for “Center” wherever appearing in section catchline and text.Enacted provision · exact public law section
(C) by striking “Center” each place such term appears and inserting “Institute”.Effective date note
Amendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.National Institutes of Health Reform Act of 2006
Pub. L. 109–482 § 101(c)(4)(B) · 120 Stat. 3675
Substituted · 42 U.S.C. § 285s(a)
Pub. L. 109–482, § 101(c)(4)(B), substituted “National Human Genome Research Institute” for “National Center for Human Genome Research” in introductory provisions
Source evidence
Code amendment note
Subsec. (a). Pub. L. 109–482, § 101(c)(4)(B), substituted “National Human Genome Research Institute” for “National Center for Human Genome Research” in introductory provisions.Enacted provision · exact public law section
(B) 42 USC 285s. by striking “National Center for Human Genome Research” each place such term appears and inserting “National Human Genome Research Institute”; andEffective date note
Amendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.
3 of 3 references resolved to an enrolled provision
Editorial Notes
Codification
Section was formerly classified to section 287c of this title prior to renumbering by Pub. L. 109–482.
Amendments
2007—Pub. L. 109–482, § 101(c)(4)(C), substituted “Institute” for “Center” wherever appearing in section catchline and text.
Subsec. (a). Pub. L. 109–482, § 101(c)(4)(B), substituted “National Human Genome Research Institute” for “National Center for Human Genome Research” in introductory provisions.
Statutory Notes and Related Subsidiaries
Change of Name
Committee on Labor and Human Resources of Senate changed to Committee on Health, Education, Labor, and Pensions of Senate by Senate Resolution No. 20, One Hundred Sixth Congress, .
Committee on Energy and Commerce of House of Representatives treated as referring to Committee on Commerce of House of Representatives by section 1(a) of Pub. L. 104–14, set out as a note preceding section 21 of Title 2, The Congress. Committee on Commerce of House of Representatives changed to Committee on Energy and Commerce of House of Representatives, and jurisdiction over matters relating to securities and exchanges and insurance generally transferred to Committee on Financial Services of House of Representatives by House Resolution No. 5, One Hundred Seventh Congress, .
Effective Date of 2007 Amendment
Amendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.
Credits
1944–2007 · 2 acts
- 1944July 1, 1944, ch. 373, title IV, § 464z–1, formerly § 485B, as added Pub. L. 103–43, title XV, § 1521(2), , 107 Stat. 180
- 2007renumbered § 464z–1 and amended Pub. L. 109–482, title I, § 101(c)(4), , 120 Stat. 3681.
Show as published
(July 1, 1944, ch. 373, title IV, § 464z–1, formerly § 485B, as added Pub. L. 103–43, title XV, § 1521(2), , 107 Stat. 180; renumbered § 464z–1 and amended Pub. L. 109–482, title I, § 101(c)(4), , 120 Stat. 3681.)